DD-Ø26ØØ5-3 - High oleic acid soybean | BCH-LMO-SCBD-14769 | Living Modified Organism | Biosafety Clearing-House
BCH Biosafety Clearing-House
CBD / BCH / Search / Record

Loading...
  |  

Living Modified Organism (LMO)

Decisions on the LMO Risk Assessments  
published: 05 Jun 2006 last updated: 16 Jan 2014
Living Modified Organism identity
The image below identifies the LMO through its unique identifier, trade name and a link to this page of the BCH. Click on it to download a larger image on your computer. For help on how to use it go to the LMO quick-links page.
High oleic acid soybean
EN
260-05 (Lines: G94-1, G94-19, G-168)
DD-Ø26ØØ5-3
  • - Organization: Pioneer Hi-Bred International Inc. () | BCH-CON-SCBD-14931-2
    Organization
    Pioneer Hi-Bred International Inc. ()
    Private sector (business and industry)
    7100 NW 62nd Avenue PO Box 1000
    Johnston, Iowa
    50131, United States of America
    Phone: +1 515 535-3200,
    Fax:
    Email:
    Website: www.pioneer.com/,
  • - Organization: DuPont () | BCH-CON-SCBD-4944-2
    Organization
    DuPont ()
    Phone:
    Fax:
    Email:
    Website: http://www.dupont.com,
Soybean lines G94-1, G94-19 and G-168 were developed through a specific genetic modification to produce a soybean oil that contains high levels of oleic acid, a monounsaturated fatty acid. These high oleic soybeans contain a second copy of fatty acid desaturase gene (fad2), which is naturally present in soybeans. The fad2 gene codes for the enzyme, delta-12 desaturase, which is involved in fatty acid synthesis. Unlike conventional soybeans, the presence of a second copy of the fad2 gene in the high oleic soybeans G94-1, G94-19 and G-168 causes a phenomenon known as "sense suppression" which results in both copies of the fatty acid desaturase gene being "switched off". This blocks the fatty acid biosynthetic pathway and results in the accumulation of oleic acid. As a consequence, polyunsaturated fatty acids (linoleic acid and linolenic acid) are only produced in very small amounts.
EN
The term “Recipient organism” refers to an organism (either already modified or non-modified) that was subjected to genetic modification, whereas “Parental organisms” refers to those that were involved in cross breeding or cell fusion.
EN
Characteristics of the modification process
pBS43 and pML102
EN
  • Biolistic / Particle gun
Some of these genetic elements may be present as fragments or truncated forms. Please see notes below, where applicable.
High oleic acid soybean produced by inserting a second copy of the fatty acid desaturase (GmFad2-1) gene from soybean, which resulted in "silencing" of the endogenous host gene.

The transgenic fad2 gene in G94-1, G94-19 and G-168 was isolated from Glycine max (soybean) and introduced into a commercial soybean variety using particle acceleration (biolistic) transformation. The genetic modification affects only the seed, allowing fatty acid biosynthesis to function normally in other plant parts such as the leaves.

The original transformant was co-bombarded with vector pML102 which contained the dapA gene from the bacterium Corynebacterium glutanicum, encoding dihydrodipicolinic acid synthase, expression of which can lead to an increase in free lysine content. The dapA gene was inserted independently from the GmFad2-1 gene and was lost via segregation, and is thus not present in the subject soybean lines.
EN
LMO characteristics
EN
  • Food
  • Feed
Detection method(s)
EN
Additional Information
High oleic soybean oil contains levels of oleic acid exceeding 80%, higher than the levels found in olive oil and rapeseed oil. This oil is lower in saturated fat, contains no trans-fatty acids, and remains in a liquid form. The high levels of oleic acid make the oil more heat-stable for cooking and edible spray applications.
Records referencing this document Show in search
Record type Field Record(s)
Laboratory for detection and identification of LMOs LMO(s) detectable by the laboratory 1
Country's Decision or any other Communication Living modified organism(s) 4
Risk Assessment generated by a regulatory process Living modified organism(s) 3

Quick links

About the BCH About the Cartagena Protocol Supplementary Protocol

Sign in Search records Submit records
National Report Analyzer

Forums BCH Announcements

Need help?

Knowledge Base FAQs Training Materials Training Site

Contact us at: bch@cbd.int
BCH Biosafety Clearing-House
Subscribe to e-mail notifications
Subscribe to our newsletter